Advertisement

Topics

Companies Related to "Matinas BioPharma NIAID Initiate Open Label Extension Phase" [Most Relevant Company Matches] RSS

17:45 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Matinas BioPharma NIAID Initiate Open Label Extension Phase" found in our extensive corporate database of over 50,000 company records.

Showing "Matinas BioPharma NIAID Initiate Open Label Extension Phase" Companies 1–25 of 1,900+

Relevant

Off-Label Ltd

Off-label.com provides biopharma with a low cost/low risk route to product development. Since launch in 2004 off-label.com has now screened 2 million Medline citations.Finding new uses for existing drugs makes commercial sense for big and small pharma says NATURE report - next decade will see the growth of a new business model (Nat Rev Drug Discov 2005 4(6) 446)


HanAll BioPharma Co., Ltd. and Open Monoclonal Technology, Inc.

HanAll BioPharma Co. Ltd is a leading R&D-based biopharmaceutical company listed on the Korean Stock Exchange. HanAll has been developing innovative and unique biologics and NCEs in immunology and oncology for the global markets as follows;

Initiate Systems

Initiate Systems enables organizations to confidently share critical data assets. Multinational corporations, healthcare organizations and government agencies rely on Initiate® software and services to deliver complete, accurate and real-time views of data spread across multiple systems, domains or databases. Initiate’s multi-domain m...


Initiate Systems, Inc.

Initiate Systems enables organizations to confidently share critical data assets. Multinational corporations, healthcare organizations and government agencies rely on Initiate® software and services to deliver complete, accurate and real-time views of data spread across multiple systems, domains or databases. Initiate’s multi-domain m...

Extension Healthcare

Extension Healthcare is leading the industry into the next generation of clinical alarm safety systems. Extension has merged advanced alarm management software with an innovative communications approach that enables clinical collaboration to occur in response to patient-related critical events via event driven secure text messaging and voice. The Extension...

EXTENSION, INC.

EXTENSION, INC. is the developer of the patent-pending EXTENSION® Solution Suite (ESS). The EXTENSION suite of software expands Cisco Unified Communications (UC) and smart phones into a clinical workflow tool automating notifications using all modern messaging platforms, including Cisco's award-winning IP Phones. EXTENSION tightly integrates any HL7- ba...

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

Kedrion Biopharma, Inc.

Kedrion Biopharma is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Kedrion Biopharma Inc., the U.S. subsidiary of Kedr...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-biopharma.com.

SAFE-BioPharma Association, LLC

As part of the National Health Information Sharing and Analysis Center (NH-ISAC), SAFE-BioPharma Association, LLC [www.safe-biopharma.org] provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries.

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab (CO:GEN) in conjunction with a financing led by Zoticon Bioventures. For more information visit www.tenxbiopharma.com.

Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals as well as for related consulting activities in terms of project management and regulatory support. The Company's clients include innovative biotech companies and m...

Exostar and SAFE-BioPharma Association

SAFE-BioPharma manages the SAFE-BioPharma global digital identity and digital signatures standard, developed for and used extensively throughout the biopharmaceutical industry. LOA 2 satisfies identity-proofing and credential issuing practices acceptable for access to systems where risk of identity fraud is minimized, including patient access to read-only ...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

Nexien BioPharma, Inc.

Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid pharmaceuticals in accordance with U.S. Food and Drug Administration ("FDA") pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. For more information, visit Nexien BioPharma’s ...

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patient...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabetes, AIDS and Alzheimer’s. BioPharma Fund invests in these innovator companies.The Fund is a sub-fund of TONIC Sector Fund SICAV, a Luxembourg-based investment company.BioPharma Fund’s Common Share...

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has two products in late stage clinical development. FluDaseTM is a first-in-class broad-spectrum investigational therapeutic agent to treat all forms of influenza, including pandemic...

BioPharma Services, Inc.

BioPharma Services Inc. is a Full-Service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa clinical trials as well as Bioequivalence trials for international pharmaceutical companies worldwide. The company has clinical facilities both in the U.S.A. and in Canada with a total bed capacity of 250 with access to healthy voluntee...

UCLA Extension

UCLA Extension is the continuing education division of the University of California at Los Angeles (UCLA). We offer courses evenings and weekends in Westwood and downtown Los Angeles, plus online classes available around the globe. Courses include business, arts, engineering, information technology, entertainment studies, public policy, public health, the ...

Artax Biopharma

Artax Biopharma is a clinical stage biopharmaceutical company developing breakthrough therapies for autoimmune diseases. Its pipeline of drugs is based on novel science that targets the interaction between T-cell receptors (TCR) and Nck, a key protein involved in T-cell activation. Based in Cambridge, Massachusetts, more information on Artax Biopharma can ...

Document Storage Systems, Inc. (DSS, Inc.)

DSS is a leading health information technology (HIT) software development and systems integration company. For more than 20 years, healthcare organizations have benefited from our technical and service integration expertise. DSS has extensive experience working with federal, private and public healthcare facilities to modernize their legacy systems and to ...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...


More From BioPortfolio on "Matinas BioPharma NIAID Initiate Open Label Extension Phase"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks